Active ingredientFlucytosineCat. No. P-F070-001CAS 2022-85-7Family · Pharmaceutical analytical standards
Flucytosine
A fluorinated cytosine analogue antifungal, first made in 1957: it is used with amphotericin B against cryptococcosis and severe candidiasis and is on the WHO List of Essential Medicines. This family brings together the active ingredient, metabolites and other impurities.
Did you know?It was first made in 1957 as a potential anticancer agent: in 1963 mouse studies showed it worked against Candida albicans and Cryptococcus neoformans, and in 1968 it was first used in humans.
Go to the active ingredient →Active ingredientFlucytosineCat. No. P-F070-001CAS 2022-85-7
MetaboliteFlucytosine GlucuronideCat. No. P-F070-002
Impurity2,5-Dimethoxypyrimidin-4(3H)-oneCat. No. P-F070-004CAS 370103-23-4
ImpurityFlucytosine Impurity 1Cat. No. P-F070-006
ImpurityFlucytosine Impurity 2Cat. No. P-F070-007
ImpurityFlucytosine Impurity 3Cat. No. P-F070-009CAS 1652-39-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceFlucytosine CRSEDQM code F0175000Family FlucytosineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.